X
skip to main content
Logo
  • September 29, 2016

    TFRI-funded research teams from coast to coast showed their true colours this year, turning out by the dozens in researcher-designated purple T-shirts and forming teams to raise funds for cancer research at the 36th Terry Fox Run on Sunday Sept. 18. Early estimates show the research community's fundraising efforts resulted in over $105,000 raised.

  • September 29, 2016

  • September 29, 2016

  • September 29, 2016

  • September 29, 2016

  • September 29, 2016

  • September 29, 2016

    Terry Fox-funded researchers have made a critical finding in monitoring breast cancer patient response to chemotherapy treatment: patient response to treatment can be detected in as little as one week by using optics and ultrasound respectively instead of waiting the traditional four to six months. Their findings were published in Oncotarget (March 2016).

  • September 27, 2016

    In 2017, TFRI will hold its Annual Scientific Meeting on November 4th to coincide with the national meeting of the Canadian Cancer Research Conference in Vancouver (Nov. 5-7th). Stay tuned for more details.

  • September 07, 2016

    Vancouver, BC – Six outstanding Canadian research teams will use $27.3 million in new funding to engineer precision medicines for patients whose cancer has relapsed or for whom current treatments are ineffective or non-existent.

  • September 07, 2016

    Triple-negative breast cancer (TNBC) persists as a deadly form of breast cancer today that lacks effective therapies. Now, a newly formed and funded Terry Fox Research Institute team hopes to employ a four-pronged approach to change the odds for TNBC patients.

  • September 06, 2016

  • September 06, 2016

    TFRI’s Vancouver-based prostate cancer progression team is primed and ready to continue its world-class research on advanced, drug-resistant tumours after receiving a five-year renewal of Terry Fox funding.

  • September 06, 2016

    TFRI’s prolific lymphoid cancer team began their research with a simple question: “Why do two-thirds of lymphoma patients recover, while the remainder does not?” A decade later their work is being renewed as they continue their mission to find solutions to this problem so all patients diagnosed with lymphoid cancer have better outcomes.

  • September 02, 2016

    Both around the world and in Canada, teams of researchers are working hard to harness the power of a patient’s own immune system to eradicate cancer through immunotherapy. Hailed now as the fourth arm of treatment, a newly funded TFRI pan-Canadian research team hopes this promising approach will give new hope and options to patients who need it the most.

  • September 02, 2016

    A newly funded TFRI “dream team” plans to tackle the most lethal and aggressive brain tumour that occurs in adults by focusing not on the original tumour, but on the relapsed cancer.

Back to Top